Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00115869 · ClinicalTrials.gov registry record · Phase 3
Hutchinson Smoking Prevention Project
A Phase 3 study, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 8,388
- Enrollment target
NCT00115869: Completed Phase 3 study, sponsored by Fred Hutchinson Cancer Center.
NCT00115869 is a Phase 3 study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 8,388 participants, above the 771-participant average among 15,282 other Phase 3 trials with a reported enrollment target (988% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00115869, a Phase 3 study, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 8,388 participants
- Enrollment target
Study Summary
The Hutchinson Smoking Prevention Project is a 16-year, group-randomized trial to determine the extent to which a school-based (grades 3-10), theory-based, social-influences tobacco use prevention intervention can deter youth tobacco use throughout and beyond high school.
Primary Outcome
Response "1 to 3 cigarettes per day," "4 to 10 cigarettes per day," "11 to 20 cigarettes per day," or "More than 20 cigarettes per day" to the Item "How often do you currently smoke cigarettes?"
Interventions
- BEHAVIORAL Social-influences
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,388 participants |
| Start Date | 1984-09 |
| Est. Completion | 1999-08 |
| Phase | Phase 3 |
What the finished NCT00115869 record still lists
NCT00115869 is an interventional study that assigns participants to a tested intervention. Its 8,388 participants enrollment target places it among the larger protocols in the corpus, above the 771-participant average among 15,282 other Phase 3 trials with a reported enrollment target (988% higher).
The record links to 0 conditions, and to 1 intervention - of which Social-influences is the first listed.
NCT00115869 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00115869 about?
NCT00115869 is a clinical study titled "Hutchinson Smoking Prevention Project". The Hutchinson Smoking Prevention Project is a 16-year, group-randomized trial to determine the extent to which a school-based (grades 3-10), theory-based, social-influences tobacco use prevention intervention can deter youth tobacco use throughout and beyond high school.
What is the current status of trial NCT00115869?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 8,388 participants. The study started on 1984-09. Estimated completion is 1999-08.
What interventions are being tested in trial NCT00115869?
The interventions under investigation include: Social-influences (BEHAVIORAL).
Who is sponsoring clinical trial NCT00115869?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00115869's enrollment target sits among peer trials
8,388 32nd of 2000 higher than 1,969 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07185828 · 8,286 participants · NA
Informing Low-acuity Emergency Department Patients of Non-emergent Resources (2)
- NCT06435806 · 8,200 participants · NA
Medical Illustration Design Characteristic Evaluation
- NCT06098079 · 8,600 participants · Phase 4
Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)
- NCT06184945 · 8,100 participants · NA
Behavioral Economic & Staffing Strategies in the ICU
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia